Transaction in Own Shares

Summary by AI BETAClose X

The Beauty Tech Group plc has purchased a total of 304,960 ordinary shares between October 13 and October 19, 2026, with weighted average prices ranging from 449.25p to 471.14p per share. These shares will be cancelled, reducing the total number of issued ordinary shares to 110,108,709, and consequently, the total voting rights. Since the commencement of its share buyback programme, the company has repurchased 592,398 ordinary shares in aggregate at a weighted average price of 429.63p.

Disclaimer*

The Beauty Tech Group PLC
20 October 2026
 

20 October 2026

The Beauty Tech Group plc

("TBTG" or the "Company")

 

 Transaction in Own Shares

 

The Beauty Tech Group plc (LSE: TBTG), a global leader in the rapidly growing at-home beauty technology market, announces it has purchased the following number of its Ordinary Shares of 10p each through Berenberg in the period from 13 October 2026 to 19 October 2026.

 

Date of

Purchase

Venue

Weighted average price per day (p)

Number of ordinary shares purchased

Lowest price per share (p)

Highest price per share (p)

13 October 2026

LSE

449.251132

112,017

444.00

450.00

14 October 2026

LSE

458.318490

130,114

448.00

465.00

15 October 2026

LSE

469.833904

23,372

460.00

472.00

19 October 2026

LSE

471.141441

39,557

469.00

472.00

 


The Company intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, TBTG will have 110,108,709 Ordinary Shares in issue and hold no Ordinary Shares in treasury.

 

The total number of voting rights in TBTG is therefore 110,108,709 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, TBTG, under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

Since the commencement of the Share Buyback Programme (including the reverse accelerated bookbuild announced on 1 October 2026), the Company has repurchased 592,398 Ordinary Shares in aggregate at a weighted average price of 429.6276 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of UK law a full breakdown of the individual trades made by Berenberg on behalf of the Company as part of the Share Buyback Programme can be found at:

 

http://www.rns-pdf.londonstockexchange.com/rns/5820Z_1-2026-10-19.pdf

 

For further information, please contact:

 

The Beauty Tech Group plc

Laurence Newman, Chief Executive Officer

Sam Glynn, Chief Financial Officer

 

Via FTI Consulting

FTI Consulting

Harriet Jackson

Amy Goldup

Harleena Chana

T: +44 (0) 20 3727 1000

tbtg@fticonsulting.com

 

Berenberg

Clayton Bush

Alex Wright

Alix Mecklenburg-Solodkoff

Ryan Mahnke

 

T: +44 (0) 20 3207 7800

 

LEI: 9845005838FE7756E729

 

About The Beauty Tech Group

 

The Beauty Tech Group is a global leader in the rapidly growing at-home beauty technology market. The Group encompasses three distinct, innovative and premium beauty technology brands - CurrentBody Skin, ZIIP Beauty and Tria Laser - under which it develops, manufactures and retails At-Home Beauty Devices using aesthetic technologies which have been used in professional clinics for decades. These technologies include LED light, RF, microcurrent, and laser therapies. The Group sells its products in the UK and internationally via its D2C e-commerce channels and via selected international retailers.

 

The Company listed on the London Stock Exchange in October 2025 under the ticker LSE: TBTG and is headquartered in Cheshire, UK.

 

For more information visit: https://www.thebeautytechgroup.com/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings